New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio ...Middle East

DUBLIN, Dec. 1, 2022 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan's Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle...

Hence then, the article about new crispr cas9 license agreement for ers genomics and cosmo bio was published today ( Thursday 01/12/2022 - 03:12 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio )

Also on site :

• BC.GAME goes double-track: partnering with Abu Dhabi T10 and Deccan Gladiators to deliver a digital-first cricket spectacle
• Two Natural Gas Stocks to Watch as Demand Surges
• LG TO UNVEIL HOME ROBOT AT CES 2026, SHARING VISION FOR THE "ZERO LABOR HOME"